Folliculitis Decalvans with tufted hairs successfully treated with oral isotretinoin and rifampicin.
DOI:
https://doi.org/10.66344/jpad.v32i1.1852Abstract
Folliculitis decalvans is a type of primary cicatricial alopecia predominantly which affects mainly middle aged males. Defective host responsive mechanism or infective etiology plays role in the pathogenesis. Clinically follicular pustules along with scarring alopecia are seen mainly over vertex and occipital area. Trichoscopy classically shows multiple tufts of hairs with serous exudates and crust. Treatment mainly aims at antimicrobial therapy along with corticosteroids & retinoid have also been tried.
References
1. Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis decalvans. Dermatol Ther. 2008;21(4):238–44.
2. Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol. 2001;19(2):211–25.
3. Rongioletti F, Christana K. Cicatricial (Scarring) Alopecias. Am J Clin Dermatol. 2012;13(4):247–60.
4. Rigopoulos D, Stamatios G, Ioannides D. Primary Scarring Alopecias. In: Ioannides D, Tosti A, editors. Current Problems in Dermatology. S. Karger AG; 2015. p. 76–86.
5. Sillani C, Bin Z, Ying Z, Zeming C, Jian Y, Xingqi Z. Effective Treatment of Folliculitis Decalvans Using Selected Antimicrobial Agents. Int J Trichology. 2010;2(1):20–3.
6. Parlette EC, Kroeger N, Ross EV. Nd:YAG laser treatment of recalcitrant folliculitis decalvans. Dermatol Surg. 2004; 30(8):1152–4.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 SUGAT AMBADAS JAWADE, Anugandha Ghatge, Bhushan Madke, Adarshlata Singh, Sudhir Singh

This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.






